NIP
XBI icon

Nicholas Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Nicholas Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-680,200
Closed -$64.7M – 210
2019
Q4 		$64.7M Buy
680,200
+118,400
+21% +$10.2M 6.66% 2
2019
Q3 		$42.8M Buy
+561,800
New +$46.7M 3.6% 2
2019
Q2 		– Sell
-309,000
Closed -$28M – 237
2019
Q1 		$28M Buy
+309,000
New +$26.3M 2.5% 3

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Nicholas Investment Partners's XBI Position: Q4 2024 in Review

Nicholas Investment Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 38,520 shares — an estimated $3.81M sold.

Nicholas Investment Partners first reported a position in XBI in Q3 2021 and held it in 4 quarters. The position peaked at $3.93M in Q3 2021. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Nicholas Investment Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 38,520 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $3.81M.
  • Nicholas Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and held it in 4 quarters.
  • Nicholas Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $3.93M in Q3 2021.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Nicholas Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.